Submission for OMB Review; Building Capacity To Evaluate Child Welfare Community Collaborations To Strengthen and Preserve Families (CWCC) Cross-Site Process Evaluation (New Collection), 2745-2746 [2020-00594]
Download as PDF
<![CDATA[
2745
Federal Register / Vol. 85, No. 11 / Thursday, January 16, 2020 / Notices
Estimated Total Annual Burden
Hours: 11,500.
Authority: Public Law 115–123, Section
511(h)(2)(A) of Title V of the Social Security
Act.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–00593 Filed 1–15–20; 8:45 am]
BILLING CODE 4184–77–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review; Building
Capacity To Evaluate Child Welfare
Community Collaborations To
Strengthen and Preserve Families
(CWCC) Cross-Site Process Evaluation
(New Collection)
Office of Planning, Research,
and Evaluation; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
The Administration for
Children and Families (ACF) at the U.S.
Department of Health and Human
Services (HHS) intends to collect data
for an evaluation of the initiative,
Community Collaborations to
Strengthen and Preserve Families (also
referred to as Child Welfare Community
Collaborations [CWCC]). The cross-site
process evaluation will provide insight
to ACF about the various factors that
SUMMARY:
promote or impede the implementation
of child welfare community
collaborations.
DATES: Comments due within 30 days of
publication. OMB is required to make a
decision concerning the collection of
information between 30 and 60 days
after publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project, Email: OIRA_
SUBMISSION@OMB.EOP.GOV, Attn:
Desk Officer for the Administration for
Children and Families.
Copies of the proposed collection may
be obtained by emailing
OPREinfocollection@acf.hhs.gov.
Alternatively, copies can also be
obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The evaluation will
involve seven data collection requests:
• Four Site Visit Discussion Guides:
To systematically document the
approaches and strategies used by the
first two cohorts of CWCC grantees
(FY18 and FY19 awardees), the
evaluation team will conduct initial and
follow-up interviews with: (1) Project
Directors from Lead Grantee
organizations and Leaders from partner
organizations, and (2) staff from the lead
and partner organizations. These
interviews will take place during site
visits. Each grantee will participate in
four site visits.
• Survey Invitee Template: The
evaluation team will ask the Project
Director of each CWCC grant to fill out
a Survey Invitee Template to gather
contact information for leaders and staff
from lead and partner organizations
who the evaluation team will invite to
complete the Collaboration Survey (see
below).
• Collaboration Survey: This
electronic survey will document
perceptions that leaders and staff from
the CWCC lead and partner
organizations have regarding their
organizational/group processes,
implementation activities, and progress
towards goals. This survey will be
administered to staff at all grantee and
partner organizations on an annual basis
during each cohort’s grant period.
• Site Visit Planning Template: Each
Project Director (or their designee) will
complete a Site Visit Planning Template
to schedule site visit activities prior to
each annual site visit.
Respondents: Leadership and staff
from CWCC lead (grantee) organizations
and from partner organizations.
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
Instrument
Number of
responses per
respondent
Average
burden hours
per
response
Total
burden hours
Annual
burden hours
Cohort 1 Data Collection for FY18 Grantees
Site Visit Discussion Guide for Project Directors and Leaders from Partner Organizations—Interview #1 .................
Site Visit Discussion Guide for Staff from Lead and Partner Organizations—Interview #1 ......................................
Site Visit Discussion Guide for Project Directors and Leaders from Partner Organizations—Follow-Up Interviews ...
Site Visit Discussion Guide for Staff from Lead and Partner Organizations—Follow-Up Interviews ........................
Survey Invitee Template ......................................................
Annual Collaboration Survey ...............................................
Site Visit Planning Template ................................................
12
1
2
24
8
36
1
1
36
12
12
2
1.5
36
12
36
4
260
4
2
3
3
3
1
1
0.5
2
72
12
390
24
24
4
130
8
khammond on DSKJM1Z7X2PROD with NOTICES
Cohort 2 Data Collection for FY19 Grantees
Site Visit Discussion Guide for Project Directors and Leaders from Partner Organizations—Interview #1 .................
Site Visit Discussion Guide for Staff from Lead and Partner Organizations—Interview #1 ......................................
Site Visit Discussion Guide for Project Directors and Leaders from Partner Organizations—Follow-Up Interviews ...
Site Visit Discussion Guide for Staff from Lead and Partner Organizations—Follow-Up Interviews ........................
VerDate Sep<11>2014
17:49 Jan 15, 2020
Jkt 250001
PO 00000
Frm 00053
Fmt 4703
27
1
2
54
18
81
1
1
81
27
27
2
1.5
81
27
81
2
1
162
54
Sfmt 4703
E:\FR\FM\16JAN1.SGM
16JAN1
2746
Federal Register / Vol. 85, No. 11 / Thursday, January 16, 2020 / Notices
ANNUAL BURDEN ESTIMATES—Continued
Total
number of
respondents
Instrument
Survey Invitee Template ......................................................
Annual Collaboration Survey ...............................................
Site Visit Planning Template ................................................
Estimated Total Annual Burden
Hours: 644.
Authority: Section 105(b)(5) of the Child
Abuse Prevention and Treatment Act
(CAPTA) of 1978 (42 U.S.C. 5106(b)(5)), as
amended by the CAPTA Reauthorization Act
of 2010 (Pub. L. 111–320).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020–00594 Filed 1–15–20; 8:45 am]
BILLING CODE 4184–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2019–D–4752]
Pediatric Study Plans for Oncology
Drugs: Questions and Answers; Draft
Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a draft
guidance for industry entitled ‘‘Pediatric
Study Plans for Oncology Drugs:
Questions and Answers.’’ This draft
guidance provides information to
sponsors regarding the submission of an
initial pediatric study plan (iPSP), as
required by the Federal Food, Drug, and
Cosmetic Act (FD&C Act), for oncology
drugs only. Specifically, when finalized,
this draft guidance will provide FDA’s
current thinking regarding iPSPs for
oncology drugs in light of the
amendments to the FD&C Act made by
the FDA Reauthorization Act of 2017
(FDARA). FDA has received a number of
questions on this topic and, as a result,
is providing this draft guidance in a
question and answer format, addressing
the most frequently asked questions.
DATES: Submit either electronic or
written comments on the draft guidance
by March 16, 2020 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:49 Jan 15, 2020
Jkt 250001
Number of
responses per
respondent
9
585
9
3
3
3
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–D–4752 for ‘‘Pediatric Study Plans
for Oncology Drugs: Questions and
Answers.’’ Received comments will be
placed in the docket and, except for
those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
Average
burden hours
per
response
1
0.5
2
Total
burden hours
27
878
54
Annual
burden hours
9
293
18
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852.
You may submit comments on any
guidance at any time (see 21 CFR
10.115(g)(5)).
Submit written requests for single
copies of the draft guidance to the
Division of Drug Information, Center for
Drug Evaluation and Research (CDER),
Food and Drug Administration, 10001
E:\FR\FM\16JAN1.SGM
16JAN1
]]>Agencies
[Federal Register Volume 85, Number 11 (Thursday, January 16, 2020)]
[Notices]
[Pages 2745-2746]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00594]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Building Capacity To Evaluate Child
Welfare Community Collaborations To Strengthen and Preserve Families
(CWCC) Cross-Site Process Evaluation (New Collection)
AGENCY: Office of Planning, Research, and Evaluation; Administration
for Children and Families; HHS.
ACTION: Request for public comment.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) at the U.S.
Department of Health and Human Services (HHS) intends to collect data
for an evaluation of the initiative, Community Collaborations to
Strengthen and Preserve Families (also referred to as Child Welfare
Community Collaborations [CWCC]). The cross-site process evaluation
will provide insight to ACF about the various factors that promote or
impede the implementation of child welfare community collaborations.
DATES: Comments due within 30 days of publication. OMB is required to
make a decision concerning the collection of information between 30 and
60 days after publication of this document in the Federal Register.
Therefore, a comment is best assured of having its full effect if OMB
receives it within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent directly to the following: Office
of Management and Budget, Paperwork Reduction Project, Email:
[email protected], Attn: Desk Officer for the Administration
for Children and Families.
Copies of the proposed collection may be obtained by emailing
[email protected]. Alternatively, copies can also be
obtained by writing to the Administration for Children and Families,
Office of Planning, Research, and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE Reports Clearance Officer. All
requests, emailed or written, should be identified by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: The evaluation will involve seven data collection
requests:
Four Site Visit Discussion Guides: To systematically
document the approaches and strategies used by the first two cohorts of
CWCC grantees (FY18 and FY19 awardees), the evaluation team will
conduct initial and follow-up interviews with: (1) Project Directors
from Lead Grantee organizations and Leaders from partner organizations,
and (2) staff from the lead and partner organizations. These interviews
will take place during site visits. Each grantee will participate in
four site visits.
Survey Invitee Template: The evaluation team will ask the
Project Director of each CWCC grant to fill out a Survey Invitee
Template to gather contact information for leaders and staff from lead
and partner organizations who the evaluation team will invite to
complete the Collaboration Survey (see below).
Collaboration Survey: This electronic survey will document
perceptions that leaders and staff from the CWCC lead and partner
organizations have regarding their organizational/group processes,
implementation activities, and progress towards goals. This survey will
be administered to staff at all grantee and partner organizations on an
annual basis during each cohort's grant period.
Site Visit Planning Template: Each Project Director (or
their designee) will complete a Site Visit Planning Template to
schedule site visit activities prior to each annual site visit.
Respondents: Leadership and staff from CWCC lead (grantee)
organizations and from partner organizations.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Instrument Total number responses per hours per Total burden Annual burden
of respondents respondent response hours hours
----------------------------------------------------------------------------------------------------------------
Cohort 1 Data Collection for FY18 Grantees
----------------------------------------------------------------------------------------------------------------
Site Visit Discussion Guide for 12 1 2 24 8
Project Directors and Leaders
from Partner Organizations--
Interview #1...................
Site Visit Discussion Guide for 36 1 1 36 12
Staff from Lead and Partner
Organizations--Interview #1....
Site Visit Discussion Guide for 12 2 1.5 36 12
Project Directors and Leaders
from Partner Organizations--
Follow-Up Interviews...........
Site Visit Discussion Guide for 36 2 1 72 24
Staff from Lead and Partner
Organizations--Follow-Up
Interviews.....................
Survey Invitee Template......... 4 3 1 12 4
Annual Collaboration Survey..... 260 3 0.5 390 130
Site Visit Planning Template.... 4 3 2 24 8
----------------------------------------------------------------------------------------------------------------
Cohort 2 Data Collection for FY19 Grantees
----------------------------------------------------------------------------------------------------------------
Site Visit Discussion Guide for 27 1 2 54 18
Project Directors and Leaders
from Partner Organizations--
Interview #1...................
Site Visit Discussion Guide for 81 1 1 81 27
Staff from Lead and Partner
Organizations--Interview #1....
Site Visit Discussion Guide for 27 2 1.5 81 27
Project Directors and Leaders
from Partner Organizations--
Follow-Up Interviews...........
Site Visit Discussion Guide for 81 2 1 162 54
Staff from Lead and Partner
Organizations--Follow-Up
Interviews.....................
[[Page 2746]]
Survey Invitee Template......... 9 3 1 27 9
Annual Collaboration Survey..... 585 3 0.5 878 293
Site Visit Planning Template.... 9 3 2 54 18
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 644.
Authority: Section 105(b)(5) of the Child Abuse Prevention and
Treatment Act (CAPTA) of 1978 (42 U.S.C. 5106(b)(5)), as amended by
the CAPTA Reauthorization Act of 2010 (Pub. L. 111-320).
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2020-00594 Filed 1-15-20; 8:45 am]
BILLING CODE 4184-25-P
